Prenetics Global Ltd
PRENasdaqHealthcare · Laboratory Analytical Instruments · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 638,920 | 2.9 | -0.8% |
| Apr 30, 2026 | 643,768 | 3.8 | +6.2% |
| Apr 15, 2026 | 606,142 | 4.4 | +5.8% |
| Mar 31, 2026 | 572,680 | 3.6 | +5.2% |
| Mar 13, 2026 | 544,485 | 2.0 | +14.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.